Live biopsy study aims to predict immunotherapy response in cancer patients
NCT ID NCT07327489
First seen Jan 10, 2026 · Last updated Jun 22, 2026 · Updated 27 times
Summary
This study is collecting live tumor samples from 2,000 cancer patients undergoing standard biopsies. Researchers will analyze these samples to understand how tumors respond to immunotherapy drugs outside the body. The goal is to develop a method to predict which patients will respond to treatment, potentially saving time and reducing side effects from ineffective therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Scott and White Biorepository
NOT_YET_RECRUITINGTemple, Texas, 76508, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Frederick Health Hospital
RECRUITINGFrederick, Maryland, 21702, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
JPS Health Network
RECRUITINGForth Worth, Texas, 76104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mercy Hospital - FTS
RECRUITINGFort Smith, Arkansas, 72903, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mercy Hospital - OKC
RECRUITINGOklahoma City, Oklahoma, 73120, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mercy Hospital - SPG
RECRUITINGSpringfield, Missouri, 65804, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mercy Hospital - South
RECRUITINGSt Louis, Missouri, 63128, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mercy Hospital -STL
RECRUITINGSt Louis, Missouri, 63141, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could lead to a test that helps doctors predict which patients will benefit from immunotherapy, avoiding ineffective treatments.
What could go wrong
This is an observational study, not a treatment trial. It is early-stage research, and the findings may not translate into a reliable clinical test for years, if at all.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.